Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on September 9, 2026

Sep. 9, 2026

Modern Fortis Appoints Phoebe Johnston as Vice President

Indeterminate EIN Presswire

Sep. 9, 2026

Dr. Augustus John Rush Discusses Advances in Treatment-Resistant Depression on the Health Policy Podcast

Indeterminate EIN Presswire

Sep. 9, 2026

Quorum Launches Quincy Hub, Bringing Its AI Agents Into One Place

Indeterminate EIN Presswire

Sep. 9, 2026

Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology (SOHO) Annual Meeting

Indeterminate GlobeNewswire

Sep. 9, 2026

AdCare Hospital Expands Detox Services with New 12-Bed Unit, Helping More People Access Care in Worcester

Indeterminate GlobeNewswire

Sep. 9, 2026

Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

Venus Concept Announces CEO Transition

Indeterminate GlobeNewswire

Sep. 9, 2026

CooperCompanies Announces Third Quarter 2026 Results

Indeterminate GlobeNewswire

Sep. 9, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Sep. 9, 2026

CooperCompanies Completes Strategic Review, Increases Share Repurchase Authorization

Indeterminate GlobeNewswire

Sep. 9, 2026

NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

NANOBIOTIX Participera à la Conférence H.C. Wainwright 28th Annual Global Investment

Indeterminate GlobeNewswire

Sep. 9, 2026

Century Therapeutics Appoints Joseph Truitt to Board of Directors

Indeterminate GlobeNewswire

Sep. 9, 2026

MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 9, 2026

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

First Infant Data from Ascendis Trial of Once-Weekly TransCon CNP (Navepegritide) Presented at ESPE 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy

Indeterminate GlobeNewswire

Sep. 9, 2026

Zoher F. Kapasi, PhD, PT, Named Provost of Thomas Jefferson University

Indeterminate GlobeNewswire

Sep. 9, 2026

AI Transforms Outpatient Surgery Through Smarter Planning and Safer Care

Indeterminate GlobeNewswire